May 18, 2017 10:03 am UTC| Business
AMES, Iowa, May 18, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that an abstract describing data from a clinical study of its IDO pathway inhibitor, indoximod, in combination with chemotherapeutic...
May 18, 2017 10:03 am UTC| Business
AMES, Iowa, May 18, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that an abstract describing data from a clinical study of its IDO pathway inhibitor, indoximod, in combination with chemotherapeutic...
May 18, 2017 10:03 am UTC| Business
AMES, Iowa, May 18, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that an abstract describing data from a clinical study of its IDO pathway inhibitor, indoximod, in combination with chemotherapeutic...
May 18, 2017 10:03 am UTC| Business
AMES, Iowa, May 18, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that an abstract describing data from a clinical study of its IDO pathway inhibitor, indoximod, in combination with chemotherapeutic...
argenx (Nasdaq: ARGX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
May 18, 2017 10:02 am UTC| Business
ADVISORY, May 18, 2017 -- What:argenx (Nasdaq:ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and...
argenx (Nasdaq: ARGX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
May 18, 2017 10:02 am UTC| Business
ADVISORY, May 18, 2017 -- What:argenx (Nasdaq:ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and...
argenx (Nasdaq: ARGX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
May 18, 2017 10:02 am UTC| Business
ADVISORY, May 18, 2017 -- What:argenx (Nasdaq:ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and...